CRISPR patent ruling has little impact in laboratory setting, MIT researchers say

By Drew Bent and Vivian Zhong Mar. 2, 2017

Researchers maintained that the U.S. Patent Trial and Appeal Board’s Feb. 15 decision giving the Broad Institute the go-ahead on editing eukaryotic genomes with CRISPR had little impact on their research.

Tagged "patent"

1 article

CRISPR patent ruling has little impact in laboratory setting, MIT researchers say

By Drew Bent and Vivian Zhong Mar. 2, 2017